Provided by Tiger Trade Technology Pte. Ltd.

ClearPoint Neuro, Inc.

15.16
-0.2300-1.49%
Volume:294.55K
Turnover:4.42M
Market Cap:462.44M
PE:-12.78
High:15.44
Open:15.40
Low:14.65
Close:15.39
52wk High:30.10
52wk Low:8.27
Shares:30.50M
Float Shares:26.30M
Volume Ratio:0.81
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1858
EPS(LYR):-0.9020
ROE:-226.52%
ROA:-24.43%
PB:42.91
PE(LYR):-16.81

Loading ...

electroCore Q2 Revenue Jumps, but Slightly Misses Estimates

Reuters
·
Aug 07

Canada's Profound Medical Q2 Loss Shrinks on Lower Costs, Revenue Hit by Shipment Timing

Reuters
·
Aug 07

Portable MRI Maker Hyperfine's Q2 Revenue Rises Less than Expected

Reuters
·
Aug 07

UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook

Reuters
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), ClearPoint Neuro (CLPT) and Keros Therapeutics (KROS)

TIPRANKS
·
Aug 04

Clearpoint Neuro Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

ClearPoint Neuro reports Q2 EPS (38c), consensus (29c)

TIPRANKS
·
Aug 04

UFP Technologies Q2 Revenue Beats Estimates on the Back of Medtech Segment

Reuters
·
Aug 04

ClearPoint Neuro Q2 Revenue Rises 18% but Misses Estimates

Reuters
·
Aug 04

ClearPoint Neuro Q2 EPS $(0.38) Misses $(0.29) Estimate, Sales $10.880M Miss $12.733M Estimate

Benzinga Earnings
·
Aug 04

ClearPoint Neuro Q2 Revenue USD 10.9 Million

Reuters
·
Aug 04

Lake Street Sticks to Its Buy Rating for ClearPoint Neuro (CLPT)

TIPRANKS
·
Aug 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 31

Clearpoint Neuro Schedules Q2 2026 Earnings Release and Conference Call

Reuters
·
Jul 22

Clearpoint Neuro CEO Joseph Burnett Disposes of 20,000 Common Shares for $387,600

Reuters
·
Jul 02

ClearPoint Neuro CEO Joseph Burnett disposes of common shares worth $1.1 million

Reuters
·
Jun 23

Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE)

TIPRANKS
·
Jun 22

ClearPoint Neuro Is Maintained at Buy by B. Riley Securities

Dow Jones
·
Jun 19

B. Riley Adjusts ClearPoint Neuro Price Target to $30 From $20, Maintains Buy Rating

MT Newswires Live
·
Jun 18

Analysts Offer Insights on Healthcare Companies: Verastem (VSTM) and ClearPoint Neuro (CLPT)

TIPRANKS
·
Jun 17